First history, then the complete five-part optic nerve function assessment, then differential diagnosis and targeted tests. Urgent red flags may precede the complete outpatient sequence; positive functional signs and an appropriate organic work-up are required before a functional visual disorder is assumed.
Terminology and draft status
Terminology review is not complete. Four entries were actually checked in the WHO UMD on 6 November 2026 using papilledema, optic neuritis, hemianopia and anisocoria. This verifies those entries, not clinical translation approval.
01Urgent triage and methodical assessment
Assessment of a patient with visual loss follows a rigorous, systematic and methodical approach. The diagnostic process is compared to assembling a puzzle: many small pieces of information from history, examination and tests only form a complete clinical picture together. 14
The diagnostic sequence is: take a detailed history, perform the complete five-part optic nerve function assessment, formulate a differential diagnosis from the findings, and then select targeted investigations to confirm or exclude diagnoses. 14
The method emphasises strong fundamental clinical skills. Premature conclusions or skipping steps in the diagnostic sequence can lead to misdiagnosis and poor outcomes. 14
An urgent triage pathway can precede completion of the full outpatient sequence because time-critical diagnoses cannot wait for all routine steps. Red flags such as rapid deterioration, severe pain or raised intracranial pressure require early assessment. 14
The lecture uses vivid comparisons such as puzzle, older and newer vehicle, or resources. They help recall the methodical approach but do not establish a specialty hierarchy or a regional underdiagnosis claim. 14
02History taking
Patient demographics refine the differential diagnosis: patients aged 20 to 40 may have inflammatory disease, while patients over 60 are more prone to vascular problems. Age alone never localises or excludes a disease. 14
The nature of visual loss includes laterality, onset and associated symptoms. Unilateral loss suggests a pre-chiasmal lesion, while bilateral loss suggests a chiasmal or post-chiasmal lesion. Bilateral retinal or optic nerve disease is also possible; localisation follows the whole clinical picture. 14
Onset and tempo are clues, not proof: acute onset suggests vascular events such as ischaemic optic neuropathy; subacute onset is typical of inflammatory disease such as optic neuritis; chronic course suggests a compressive lesion such as a tumour. Transient or sudden visual loss requires urgent pathways. 14
Associated symptoms narrow the differential diagnosis: systemic symptoms such as temporal headache, jaw claudication, weight loss or night sweats point to giant cell arteritis (GCA); neurological symptoms such as facial numbness, speech difficulty, limb weakness, pain on eye movement, paraesthesia or incontinence suggest stroke or demyelinating disease such as multiple sclerosis; intracranial pressure symptoms such as weight gain, pulsatile tinnitus or headache worsening on bending forward are typical of idiopathic intracranial hypertension (IIH). 3 9 10
Past ocular history can confound: amblyopia with patching, previous eye surgery, trauma or refractive surgery such as LASIK. Previous LASIK can lead to late corneal ectasia mimicking a neurological decline in vision. General medical history includes cardiovascular risk, diabetes, multiple sclerosis, thyroid disease and granulomatous disease such as tuberculosis or sarcoidosis. 14
Ask specifically and neutrally about occupation, diet, alcohol, tobacco and medicines. Restrictive diets may matter through vitamin B12 deficiency; the original blanket classification of all listed medicines as toxic or ischaemic optic neuropathies is incorrect. Doxycycline and corticosteroid withdrawal may be associated with raised intracranial pressure, ethambutol with toxic neuropathy; semaglutide carries a very rare regulatory NAION warning. Sildenafil (Viagra), steroids, anti-tuberculous medicines and weight-loss injections (Wegovy) remain targeted history items without establishing individual causality. 5 9
| History component | Key questions and considerations | Clinical significance |
|---|---|---|
| Patient demographics | Age: Is the patient in the 20-40 age range or over 60? | Younger patients may have inflammatory conditions, while older patients are more prone to vascular issues. |
| Nature of vision loss | Laterality: Is it one eye (unilateral) or both (bilateral)? | Unilateral loss suggests a pre-chiasmal finding; bilateral loss can also arise from bilateral retinal or optic nerve disease. Assess chiasmal or post-chiasmal causes from the pattern. |
| Onset: Was it sudden (acute), progressing over days/weeks (sub-acute), or long-term (chronic)? | Acute: Suggests vascular events (e.g., ischaemic optic neuropathy). Sub-acute: Typical for inflammatory conditions like optic neuritis. Chronic: Suggests a compressive lesion, such as a tumour. | |
| Associated symptoms | Systemic symptoms: Any temporal headaches, jaw claudication, weight loss, night sweats? | Giant cell arteritis is an urgent differential with irreversible visual loss risk. The original claim of particular underdiagnosis in Syria is unverified. |
| Neurological symptoms: Any facial numbness, speech difficulty, limb weakness, pain on eye movement, pins and needles, or incontinence? | Suggests stroke or demyelinating disease like Multiple Sclerosis (MS). | |
| Intracranial pressure symptoms: Any weight gain, pulsatile tinnitus (a "whooshing" sound in sync with the pulse), or headaches that worsen when bending forward? | Clues to raised intracranial pressure, not a diagnosis of IIH. Exclude secondary causes. | |
| Past ocular history (POH) | History of patching for amblyopia ("lazy eye"), prior eye surgeries, trauma, or refractive surgery (e.g., LASIK)? | A history of amblyopia can be a confounder. Past LASIK can lead to late-onset corneal ectasia, mimicking a neurological decline in vision. |
| Past medical history (PMH) | Any cardiovascular risks (hypertension, diabetes), known MS, thyroid disease, or granulomatous diseases like Tuberculosis (TB) or Sarcoidosis? | These conditions have well-known neuro-ophthalmic manifestations (e.g., ischaemic events, optic neuritis, thyroid eye disease). |
| Social & medication history | Profession/Diet: What is the patient's job? Any restrictive diets (e.g., vegan, selective eating in autism)? | Possible access to dilating drops, for example in nursing, establishes neither use nor intent. Restrictive vegan diets or selective eating, including in autism, do not establish deficiency; assess nutrition and vitamin B12 where indicated. |
| Substances/Medications: Use of alcohol, tobacco, steroids, doxycycline, sildenafil (Viagra), anti-TB drugs, or newer weight-loss injections (e.g., Wegovy)? | Correct the original joint toxic/ischaemic classification: distinguish toxic, vascular and pressure-related mechanisms; ask openly and without judgement. |
03Visual acuity and colour vision
Visual acuity is tested in each eye separately, with and without refractive correction and with pinhole. Metrics such as Snellen 6/6, logMAR or 20/20 are recorded for documentation and communication. Normal acuity does not exclude severe field or disc abnormalities. 14
Colour impairment may suggest optic nerve dysfunction. Ishihara plates mainly test red–green discrimination and do not detect every acquired disorder equally well. The original “acquired random, congenital predictable” rule and 6/18 threshold are not validated here as general diagnostic rules. 14
Mobile colour vision apps can be a useful alternative but must be assessed individually and device-specifically: one study of 77 people on an iPhone 8 Plus reported AUC values of 0.812, 0.778 and 0.736 for two apps and the Ishihara booklet; another with 42 normal trichromats and 38 colour-deficient people found 100 per cent sensitivity but specificities of 95.2 and 54.8 per cent; a further iPad study in suspected optic neuritis provided no sample size or accuracy values. These abstracts do not establish general equivalence of arbitrary free apps. 11 12 13
04Pupil examination and RAPD
Pupil examination is an objective vital sign of optic nerve health. The technique requires a darkened room, distant fixation to avoid accommodative miosis, the examiner at eye level, inspection of size, shape and symmetry, and testing of direct and consensual constriction with bright light for 2 to 3 seconds. 7
The swinging torch test moves light briskly from one eye to the other and back within 1 second, repeated several times. The lecture values of 2 to 3 seconds per eye and switching within 1 second are lecture values. A practical source describes at least 3 seconds per eye and a rapid switch; no validation is available for the original cut-offs. 7
An RAPD means asymmetric dysfunction of the afferent pupillary pathway and is a sign of unilateral or markedly asymmetric optic nerve disease or severe retinal disease. Symmetric bilateral disease produces no RAPD, and the defect causes no anisocoria. An RAPD is evidence of afferent asymmetry, not proof of optic neuritis. When the light moves to the more affected side, both pupils may relatively dilate because the afferent light signal is weaker. 7 8
Absence of an RAPD in significant unilateral visual loss is not positive evidence of a functional visual disorder. A small historical series found a mild afferent defect in 4 of 45 amblyopic people, 3 with acuity better than 20/100; this contradicts an absolute rule that only extremely dense amblyopia produces an RAPD. Positive functional signs and an appropriate organic work-up remain necessary; functional and organic disease can coexist. 1 2 8
05Optic disc and OCT
Examine disc shape and tilt, pallor, margins and swelling, together with vessels and splinter haemorrhages. Include peripapillary atrophy and cotton-wool spots; optical coherence tomography (OCT) supplements examination with retinal nerve fibre layer and ganglion cell measurements. 14
An unremarkable fundus or OCT does not exclude retrobulbar or early disease. Disc swelling, papilloedema and other causes of bilateral disc swelling must be distinguished; not every swollen disc proves raised intracranial pressure. 3 9
Papilloedema and suspected raised intracranial pressure require cause-finding before an IIH diagnosis: blood pressure, formal visual fields and an extended fundus examination form part of assessment; in the described pathway MRI or CT with venography precede lumbar puncture. Symptoms such as weight gain or oral contraceptive use are not diagnostic criteria; imaging must exclude a mass or cerebral venous thrombosis and assess contraindications. 3 9
06Visual fields and evidence
Confrontation testing is a simple, free screening tool in the clinic. It includes four quadrants, knee-to-knee positioning, occlusion of the untested eye, fixation on the nose and static fingers or kinetic red targets. 14
The reported 90 per cent for hemianopias and 51 per cent for arcuate scotomas come from a prospective study of 72 people with one eye per person, testing moving fingers in opposite quadrants; it was not a combined finger-counting or red-target test. Overall 63 per cent of abnormal fields and only 38 per cent of abnormal quadrants were detected; the central 15 degrees were excluded. Small subgroups, a highly selected clinic spectrum and differing defect density limit generalisability; a negative confrontation test does not exclude a defect. A different study using a combined static finger-wiggle protocol reported 78.3 per cent sensitivity and 90.1 per cent specificity; these protocols are not interchangeable. 4 6
Automated perimetry such as Humphrey visual fields remains the gold standard for detailed quantitative assessment. It is complementary to confrontation testing and not a replacement that should delay urgent evaluation. 14
07All four cases
Case 1: A 38-year-old woman with headache, blurred vision and bumping into things had 6/6 vision in both eyes and no RAPD, but the visual field showed a clear bitemporal hemianopia. The diagnosis was chiasmal compression. Normal acuity does not exclude significant pathology; a localising field pattern does not justify delaying indicated urgent imaging until every test is complete. 14
Case 2: A 20-year-old woman with gradual unilateral visual loss over one week, reduced colour vision and a definite right RAPD had retrobulbar optic neuritis with an unremarkable fundus. The RAPD was objective evidence of an organic afferent lesion and required urgent neurological assessment. RAPD supports asymmetric afferent dysfunction, not specifically a neuritis diagnosis; retinal or other neuropathy differentials remain relevant. 7
Case 3: Identical history and symptoms, but no RAPD with reduced colour vision and unremarkable fundus. The original conclusion of functional visual loss and avoidance of urgent MRI must be corrected: absence of an RAPD alone cannot redirect urgent care or establish voluntary symptoms. Positive functional signs and an appropriate organic work-up are required; functional and organic disease can coexist. 1 2
Case 4: A 21-year-old woman with severe headaches, tinnitus, high BMI and oral contraceptive use had 6/6 vision, normal colour vision and no RAPD, but bilateral disc swelling consistent with papilloedema and IIH in the differential diagnosis. Excellent acuity is a poor safety indicator because the optic nerve can fail suddenly and irreversibly under sustained pressure. 3 9
Case 4 still requires immediate admission for imaging, with blood pressure, formal visual fields and an extended fundus examination as part of assessment, and appropriate brain imaging including venography before lumbar puncture in the described pathway. BMI and contraceptive use are not diagnostic criteria; secondary causes, mass or cerebral venous thrombosis must be excluded and contraindications assessed. 3 9
| Case scenario | Patient profile & symptoms | Key examination findings | Diagnosis & clinical lesson |
|---|---|---|---|
| Case 1: The misleadingly good vision | 38 y/o female with headaches, blurry vision, and "bumping into things." | Vision: 6/6 in both eyes. No RAPD. The crucial test was the visual field, which revealed a clear bitemporal hemianopia. | Chiasmal compression in the teaching case. Despite 6/6, the bitemporal field is localising; the 5-part examination must not delay indicated urgent imaging. |
| Case 2: The decisive RAPD | 20 y/o female with gradual, unilateral vision loss over one week and mild headache. | Reduced colour vision and red desaturation in the affected eye. A definite right RAPD was present. Fundus exam was normal. | Teaching diagnosis of retrobulbar optic neuritis. “Patient sees nothing, doctor sees nothing” describes the normal fundus, not a definitive diagnosis; RAPD indicates afferent asymmetry, with other causes and urgent assessment still needed. |
| Case 3: The absent RAPD | Identical history and symptoms to Case 2. | Reduced colour vision. However, there was NO RAPD. The fundus exam was normal. | Originally labelled functional; absence of RAPD alone does not justify that conclusion. Positive functional signs and organic assessment are required; do not cancel urgent MRI on this basis alone. |
| Case 4: The silent threat | 21 y/o female with severe headaches, tinnitus, high BMI, on oral contraceptives. | Vision: 6/6. Colour vision: Normal. No RAPD. However, the fundus exam showed bilateral optic disc swelling (papilloedema). | Suspected papilloedema with possible IIH, not an established cause. Immediate hospital assessment; despite good acuity, imaging including venography to exclude mass/thrombosis precedes lumbar puncture and assessment of its contraindications. |
08Integration and limits
The five functional areas are acuity, colour vision, pupils, disc with OCT and visual fields. History, findings and course determine the differential diagnosis and next investigations; a single normal test does not end assessment. 14
Source limits remain visible: the original recording, transcript and lecturer attribution were not checked; the attribution to Dr Haya Razzouk comes from the export. Some sources were read only as abstracts, consensus or selected text. These limits do not change the clinical warning signs but must not be presented as a completed source review. 14
The original questions and patient guidance are retained. The two revision questions ask for the main learning points and for findings requiring urgent assessment. The three patient paragraphs explain the examination, warn about symptoms and emphasise that this information does not replace personal diagnosis or treatment. 14
What are the most important learning points of the lecture "Briefing Document: Assessment of the Visual Loss Patient"?
Assessment of visual loss requires a detailed history, then the complete five-part optic nerve function assessment, then a differential diagnosis and targeted investigations. Absence of an RAPD alone is not a positive functional diagnosis, and urgent triage can precede the outpatient sequence.
Which findings require urgent assessment?
Rapid visual decline, severe pain, marked inflammation, raised intracranial pressure or suspected infectious, vascular or neurological cause require urgent medical assessment. Papilloedema and suspected raised intracranial pressure still require cause-finding before an IIH diagnosis.
References and access status
- 1Management of Functional Vision Disorders
Complete actual NCBI abstract and selected indexed introduction/comorbidity passages read. Direct PMC webpage browser check; not complete main report or underlying studies.
- 2Functional Vision Disorders in adults: A paradigm and nomenclature shift for ophthalmology
Actual official NCBIPMCXML title/metadata verified; Introduction, S3 diagnostic criteria, S6 visual acuity approach, S14 RAPD, S20 field discussion, S24 work-up and Conclusion text read. Webpage browser check. Not every subsection, table, image or underlying study.
- 3Idiopathic intracranial hypertension: consensus guidelines on management
Abstract/scope and selected actual diagnostic-principles/Q1, associated-condition table, neuroimaging, LP and uncertainty text read. Not whole 2018 guideline, figures, supplements or latest-update appraisal. Journal web 403; PMC text accessible.
- 4Diagnostic accuracy of confrontation visual field tests
Complete actual NCBI abstract read. Full protocol, confidence intervals, subgroup tables and bilateral-eye statistics unread.
- 5EMA/PRAC semaglutide NAION safety communication 2025
Entire actual communication text including 13 June 2025 revision note read. Regulatory assessment, not current label or underlying-study full appraisal.
- 6Confrontation visual field loss as a function of decibel sensitivity loss on automated static perimetry
Actual AOA-hosted PDF downloaded; abstract/methods/results/discussion pp872-877 read. Table 1 p874 visually inspected. Not all figures or Table 2 visually inspected or cited studies appraised. Web PDF retrieval failed before direct download succeeded.
- 7How to test for a relative afferent pupillary defect (RAPD)
Actual main text steps/specific situations/causes and Table 1 read. Figures not individually inspected. Practical educational article, not diagnostic-accuracy validation.
- 8Afferent pupillary defects in amblyopia
Complete actual PubMed abstract read. Historical small observational series/case-report indexing; full report and protocol unread.
- 9Diagnosis, treatment and monitoring of idiopathic intracranial hypertension: Consensus recommendations of the Austrian IIH network (AN4IH)
Actual abstract/introduction/methods/target population/diagnostic section with Table 1/imaging/CSF/differential/criteria/Considerations text read. Not complete treatment/monitoring/pregnancy/supplement/figure appraisal. Consensus guidance, not empirical evidence grade.
- 10DOG/RG/BVA S2e retinale arterielle Verschlüsse, Version 7.10.2022
Introduction and methodology and selected diagnosis text pp. 2–4 and 7–10 read; version 7 October 2022. No complete therapy/image appraisal or verified current validity.
- 11Digital Color Vision Testing in Optic Neuropathy: Are Smartphone Apps Ready for Clinical Use?
Complete actual official NCBI PubMed XML abstract read. Webpage inaccessible/check/empty. No full report, protocol, confidence intervals, supplement or app code; individual app/device/population limits apply.
- 12Comparison of Ishihara Booklet with Color Vision Smartphone Applications.
Complete actual official NCBI PubMed XML abstract read. Webpage inaccessible/check/empty. No full report, protocol, confidence intervals, supplement or app code; individual app/device/population limits apply.
- 13iPad colour vision apps for dyschromatopsia screening.
Complete actual official NCBI PubMed XML abstract read. Webpage inaccessible/check/empty. No full report, protocol, confidence intervals, supplement or app code; individual app/device/population limits apply.
- 14Original exported teaching text
Complete archived original text read; unverified teaching claims are not independent medical evidence. Recording/attribution unchecked.
Original lecture link
- Assessment of Visual Loss Patient | تقييم مريض فقدان البصر
Original exported link retained; recording/transcript and lecturer attribution not checked.
For patients
Visual loss can arise from disease of the eye, optic nerve or visual pathway. Examination determines the cause; normal acuity or an unremarkable fundus does not exclude serious disease.
Many causes are treatable when recognised early. Medicines, diets or eye drops should only be used after personal medical assessment; not all visual changes should be attributed to neurological causes without examination.
Seek immediate medical help for sudden visual deterioration, severe pain, a new visual field defect, double vision, weakness, speech disturbance or severe headache. This information does not replace personal examination or treatment advice.
Urgent medical assessment is needed for rapid visual decline, severe pain, marked inflammation, raised intracranial pressure, or suspected infectious, vascular or neurological cause. Papilloedema and suspected raised intracranial pressure still require cause-finding before an IIH diagnosis.